Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.43 |
| ▸ | GRM5 | P41594 | 4/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20689908 | 0.90 | EGLN1 (0.45) | CYP2A6EGLN1NPC1RAB9AMAPT | |
| SCHEMBL20689849 | 0.88 | CYP2A6 (0.41) | CYP2A6EGLN1HTTNPC1RAB9A | |
| SCHEMBL20689906 | 0.84 | HTT (0.46) | CYP2A6EGLN1HTTMAPTELANE | |
| SCHEMBL20689853 | 0.84 | HTT (0.49) | CYP2A6EGLN1HTTMAPTELANE | |
| SCHEMBL20689956 | 0.83 | CYP11B2 (0.38) | EGLN1GRM5HTTL3MBTL1AR | |
| SCHEMBL21453943 | 0.83 | HTT (0.50) | CYP2A6EGLN1HTTMAPTELANE | |
| SCHEMBL20689815 | 0.82 | ALDH1A1 (0.39) | EGLN1HTTNPC1TP53RAB9A | |
| SCHEMBL20689816 | 0.81 | CYP3A4 (0.37) | EGLN1HTTMAPTELANEL3MBTL1 | |
| SCHEMBL20689847 | 0.79 | HTT (0.44) | CYP2A6EGLN1HTTMAPTELANE | |
| SCHEMBL18959488 | 0.78 | EGLN1 (0.48) | CYP2A6EGLN1MAPTPDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11018306-B2 | Compound for thermally activated delayed fluorescence and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-05-25 | — | — | US | disclosed |
| US-20190036034-A1 | COMPOUND FOR THERMALLY ACTIVATED DELAYED FLUORESCENCE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11018306-B2 | Compound for thermally activated delayed fluorescence and organic electroluminescence device including the same | TRPA1, SLCO2A1, TMEM109 | CYP2A6 2829/4885EGLN1 2128/4885GRM5 3243/4885 |
| US-20190036034-A1 | COMPOUND FOR THERMALLY ACTIVATED DELAYED FLUORESCENCE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | TRPA1, SLCO2A1, TMEM109 | CYP2A6 2829/4885EGLN1 2128/4885GRM5 3243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.